Pretraga

Rezultati

Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. [2024]

Zahm, Shelia; Bonde, Jens Peter; Chiu, Weihsueh A; Hoppin, Jane; Kanno, Jun; Abdallah, Mohamed; Blystone, Chad R; Calkins, Miriam M; Dong, Guang-Hui; Dorman, David C;

Fry, Rebecca; Guo, Huan; Haug, Line S; Hofmann, Jonathan N; Iwasaki, Motoki; Machala, Miroslav; Mancini, Francesca R; Maria-Engler, Silvya S; Møller, Peter; Ng, Jack C; Pallardy, Marc; Post, Gloria B; Salihovic, Samira; Schlezinger, Jennifer; Soshilov, Anatoly; Steenland, Kyle; Steffensen, Inger-Lise; Tryndyak, Volodymyr; White, Alexandra; Woskie, Susan; Fletcher, Tony; Ahmadi, Ayat; Ahmadi, Nahid; Benbrahim-Tallaa, Lamia; Bijoux, Wendy; Chittiboyina, Shirisha; de Conti, Aline; Facchin, Caterina; Madia, Federica; Mattock, Heidi; Merdas, Mira; Pasqual, Elisa; Suonio, Eero; Viegas, Susana; Zupunski, Ljubica ; Wedekind, Roland; Schubauer-Berigan, Mary K;

Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial [2021]

Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S. ; ...; (broj koautora 23)

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial [2015]

Blay, Jean-Yves; Pápai, Zsuzsanna; Tolcher, Anthony W; Italiano, Antoine; Cupissol, Didier; López-Pousa, Antonio; Chawla, Sant P; Bompas, Emmanuelle; Babović, Nada ; Penel, Nicolas;

Isambert, Nicolas; Staddon, Arthur P; Saâda-Bouzid, Esma; Santoro, Armando; Franke, Fabio A; Cohen, Patrick; Le-Guennec, Solenn; Demetri, George D;

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data [2017]

Guinney, Justin; ...; Krstajic, Damjan; ...; (broj, koautora 196)

Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 [2026]

Bhangdia, Kayleigh; ...; Ilić, Irena M. ; Ilić, Milena D. ; ...; Jakovljević, Mihajlo ; ...; Šantrić-Milićević, Milena M. ; ...; (broj koautora 1019)

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study [2023]

Leal, Ticiana A; ...; Andric, Zoran G ; ...; (broj, koautora 25)

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network [2023]

Ludwig, Heinz; ...; Bila, Jelena S. ; ...; (broj koautora 29)

Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial [2018]

von, Minckwitz Gunter; Colleoni, Marco A; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia Xavier; Tomasevic, Zorica I ; Zhang, Nan; Hanes, Vladimir

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial [2014]

Stupp, Roger; ...; Grujicic, Danica M; ...; (broj, koautora 37)

Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement [2025]

Kyrgiou, Maria; Bowden, Sarah J; Ellis, Laura Burney; Hammer, Anne; Lyons, Deirdre; Freeman, Wang Theresa; Kechagias, Konstantinos S; Kalliala, Ilkka; Preti, Mario; Kesic, Vesna I;

Zapardiel, Ignacio; Cruickshank, Margaret; Gultekin, Murat; Martin, Hirsch Pierre;